What is Calbiotech?
Headquartered in California, Calbiotech operates as a premier contract development and manufacturing organization (CDMO) serving the life sciences sector. The company distinguishes itself through a comprehensive portfolio of ELISA and CLIA assays, catering to both human and animal research markets. Beyond its product catalog, Calbiotech provides high-value technical services, including custom conjugation, assay optimization, and end-to-end regulatory support. With over two decades of operational history, the firm acts as a vital partner for diagnostics companies, ensuring that complex manufacturing processes remain compliant with stringent U.S. quality standards and regulatory frameworks.
How much funding has Calbiotech raised?
Calbiotech has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Calbiotech
PPP
Public-Private Partnership
What's next for Calbiotech?
With this late-stage financing, Calbiotech is positioned to accelerate its operational footprint and enhance its technological infrastructure. The strategic deployment of this capital will likely focus on expanding manufacturing capacity to accommodate the increasing global demand for high-precision diagnostic tools. Furthermore, the company is expected to deepen its investment in regulatory compliance and quality assurance systems, reinforcing its reputation as a reliable partner for large-scale diagnostic firms. As the biotech industry continues to prioritize streamlined development cycles, Calbiotech's end-to-end service model provides a competitive advantage, enabling the firm to capture additional market share in the evolving landscape of clinical and research diagnostics.
See full Calbiotech company page
